Skip to content

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Merck & Co. logo
Merck & Co.MRK
6.5×+1.8×
UroGen Pharma logo
UroGen PharmaURGN
20.5×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
3.1×+1.7×
CG Oncology logo
CG OncologyCGON
5.2×+2.6×
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
3.3×+2.9×

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Calculated from Aura Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s price / book?
Aura Biosciences, Inc. (AURA) reported price / book of 4× in Q1 2026.
How has Aura Biosciences, Inc.'s price / book changed year-over-year?
Aura Biosciences, Inc.'s price / book increased by 74.0% year-over-year, from 2.3× to 4×.
What is the long-term trend for Aura Biosciences, Inc.'s price / book?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s price / book has grown at a -6.1% compound annual growth rate (CAGR), from 3.3× to 2.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.